Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he is taking steps to regulate commercially available prostate specific antigen tests; and if he will produce clinical guidance to ensure the promotion of (a) clear and (b) evidence-based public health messaging on the (i) risk of prostate cancer and (ii) options for testing.

In January 2024, the UK National Screening Committee updated its information on paid-for private screening tests, and how they differ from National Health Service screening programmes.

The updated guidance sets out the potential benefits and harms of all screening, including summarising some additional possible issues for people to think about if considering commercially offered health screening tests. These issues include that commercial companies often only offer a test, rather than an end-to-end screening pathway. If an individual then receives an abnormal finding, it is up to them to seek any advice, further investigation, or treatment.

Furthermore, NHS England is taking steps to raise awareness of the symptoms of prostate cancer, where there are opportunities to do so. NHS England’s Getting It Right First Time programme published guidance in April 2024 to support the implementation of good practice in the management of prostate cancer, which includes ensuring that the diagnostic pathways for prostate cancer were implemented from a primary care setting to a secondary care presentation.

The Government recognises that a cancer-specific approach is needed to meet the challenges in cancer care, and to improve all cancer services and outcomes for people living with cancer, including those with prostate cancer. The Department is investing £16 million into the Prostate Cancer UK-led TRANSFORM screening trial, which seeks to find better ways of detecting prostate cancer. This trial will compare the most promising tests that look for prostate cancer in men that do not have symptoms, and aims to address disparities in detection rates across different groups.

As recently announced, we will publish a new National Cancer Plan, which will include further details on how we will improve cancer services across England, including for those living with prostate cancer.